跳至主要内容
临床试验/NCT06282562
NCT06282562招募中不适用

FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients: a Randomized Controlled Trial

Amsterdam UMC, location VUmc2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
36
试验地点
2
主要终点
Self-reported physical fitness

研究概览

简要总结

The FeelFit study aims to assess the effectiveness of High-Intensity Interval Training (HIIT) in improving self-reported physical fitness in adult brain tumor patients during periods of stable disease, as compared to a waiting-list control group. Furthermore, several secondary and exploratory outcomes will be evaluated. The study is part of the GRIP (GuaRding quality survivorshiP) project, which aims to improve quality of life in brain tumor patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • reduced self-reported physical fitness;
  • minimum age of 18 years;
  • diagnosed with a primary brain tumor;
  • stable disease, i.e. no signs of radiological or clinical tumor progression;
  • no oncological treatment for at least two months prior to inclusion;
  • able to speak, read and write in Dutch.

排除标准

  • Karnofsky Performance Score < 70;
  • already participated in a HIIT program < 1 month prior;
  • contraindication of exercise.

结局指标

主要结局

Self-reported physical fitness

时间窗: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)

Self-reported physical fitness is measured using the first question of the International Fitness Scale (IFIS) on general physical fitness, on a 5-point scale where a higher score corresponds to better self-reported physical fitness.

次要结局

  • Self-reported fitness(Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up))
  • VO2max(Baseline versus post-intervention (12 weeks))

研究者

发起方
Amsterdam UMC, location VUmc
申办方类型
Other
责任方
Principal Investigator
主要研究者

Linda Douw

Principal Investigator

Amsterdam UMC, location VUmc

研究点 (2)

Loading locations...

相似试验